Related Experiment Videos
Hypercontractile heart failure caused by catecholamine therapy in premature neonates
I Germanakis1, C Bender, R Hentschel
1Department of Congenital Heart Disease, Albert-Ludwigs-University Hospital, Freiburg, Germany.
Acta Paediatrica (Oslo, Norway : 1992)
|August 2, 2003
Summary
Beta-agonist medications can cause paradoxical hypotension in premature infants with heart conditions. Norepinephrine is an effective alternative treatment for hypotension in these critical cases.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Pharmacology
Background:
- Hypotension is frequently treated with catecholamines in neonatal intensive care units.
- Left ventricular hypertrophy can complicate catecholamine treatment, potentially causing adverse effects.
Observation:
- Two very low birthweight infants with left ventricular hypertrophy developed paradoxical hypotension during beta-agonist treatment post-surgery.
- Echocardiography revealed complete systolic obliteration of the left ventricular cavity in both infants.
Findings:
- Beta-agonist medications (epinephrine, dobutamine) were ineffective in treating hypotension.
- Switching to norepinephrine successfully managed the hypotension and ventricular obliteration.
Implications:
- Beta-agonist therapy for hypotension in VLBW infants with left ventricular hypertrophy carries a risk of hypercontractility and paradoxical hypotension.
- Close echocardiographic monitoring is crucial for identifying and managing this complication.